Elizabeth Round

1.0k total citations
12 papers, 648 citations indexed

About

Elizabeth Round is a scholar working on Endocrinology, Diabetes and Metabolism, Urology and Pharmacology. According to data from OpenAlex, Elizabeth Round has authored 12 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Urology and 4 papers in Pharmacology. Recurrent topics in Elizabeth Round's work include Diabetes Treatment and Management (6 papers), Peptidase Inhibition and Analysis (3 papers) and Pharmacology and Obesity Treatment (3 papers). Elizabeth Round is often cited by papers focused on Diabetes Treatment and Management (6 papers), Peptidase Inhibition and Analysis (3 papers) and Pharmacology and Obesity Treatment (3 papers). Elizabeth Round collaborates with scholars based in United States, United Kingdom and Australia. Elizabeth Round's co-authors include Keith D. Kaufman, Samuel S. Engel, Gregory T. Golm, Barry J. Goldstein, Michael J. Davies, Debora Williams‐Herman, Bret J. Musser, Jeremy Johnson, Hua Guo and John M. Amatruda and has published in prestigious journals such as The Journal of Urology, European Urology and Journal of the American Academy of Dermatology.

In The Last Decade

Elizabeth Round

12 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Round United States 11 467 179 160 141 108 12 648
Luis Resel Spain 8 126 0.3× 89 0.5× 31 0.2× 197 1.4× 50 0.5× 30 524
Christian Wallner Netherlands 10 51 0.1× 75 0.4× 144 0.9× 266 1.9× 66 0.6× 20 529
Joanna K. Chon United States 8 116 0.2× 67 0.4× 18 0.1× 94 0.7× 25 0.2× 11 379
Tomohiko Yanagida Japan 13 64 0.1× 78 0.4× 94 0.6× 83 0.6× 75 0.7× 30 588
Roberto L. Müller United States 9 121 0.3× 76 0.4× 67 0.4× 56 0.4× 19 0.2× 25 372
Toshifumi Nakamura Japan 14 115 0.2× 91 0.5× 176 1.1× 237 1.7× 100 0.9× 40 552
N. Nakamura Japan 9 73 0.2× 196 1.1× 34 0.2× 115 0.8× 42 0.4× 13 417
Harry Nísen Finland 12 88 0.2× 196 1.1× 76 0.5× 115 0.8× 41 0.4× 40 450
Norman Heyden United States 7 62 0.1× 126 0.7× 164 1.0× 66 0.5× 65 0.6× 8 498
Hsiang‐Ying Lee Taiwan 11 24 0.1× 101 0.6× 78 0.5× 122 0.9× 54 0.5× 73 466

Countries citing papers authored by Elizabeth Round

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Round's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Round with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Round more than expected).

Fields of papers citing papers by Elizabeth Round

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Round. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Round. The network helps show where Elizabeth Round may publish in the future.

Co-authorship network of co-authors of Elizabeth Round

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Round. A scholar is included among the top collaborators of Elizabeth Round based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Round. Elizabeth Round is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
3.
Round, Elizabeth, Samuel S. Engel, Gregory T. Golm, et al.. (2014). Safety of Sitagliptin in Elderly Patients with Type 2 Diabetes: A Pooled Analysis of 25 Clinical Studies. Drugs & Aging. 31(3). 203–214. 32 indexed citations
4.
Engel, Samuel S., Elizabeth Round, Gregory T. Golm, Keith D. Kaufman, & Barry J. Goldstein. (2013). Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies. Diabetes Therapy. 4(1). 119–145. 105 indexed citations
5.
Olsen, Elise A., David A. Whiting, R Savin, et al.. (2012). Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo. Journal of the American Academy of Dermatology. 67(3). 379–386. 30 indexed citations
6.
Williams‐Herman, Debora, Samuel S. Engel, Elizabeth Round, et al.. (2010). Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocrine Disorders. 10(1). 7–7. 215 indexed citations
7.
Williams‐Herman, Debora, Elizabeth Round, Arlene S. Swern, et al.. (2008). Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis. BMC Endocrine Disorders. 8(1). 14–14. 106 indexed citations
8.
Kaufman, Keith D., Cynthia J. Girman, Elizabeth Round, et al.. (2008). Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.. PubMed. 18(4). 407–11. 18 indexed citations
9.
Stoner, Elizabeth, et al.. (1994). Clinical Experience of the Detection of Prostate Cancer in Patients with Benign Prostatic Hyperplasia Treated with Finasteride. The Journal of Urology. 151(5). 1296–1300. 20 indexed citations
10.
Beisland, Hans Olav, Bruce Binkowitz, Peter Ekman, et al.. (1992). Scandinavian Clinical Study of Finasteride in the Treatment of Benign Prostatic Hyperplasia. European Urology. 22(4). 271–277. 37 indexed citations
11.
Watt, B., M.C. Kelsey, S.W.B. Newsom, et al.. (1984). Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial. Journal of Antimicrobial Chemotherapy. 13(suppl B). 89–94. 24 indexed citations
12.
Vogel, Roger, et al.. (1984). Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid: A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections. Journal of Antimicrobial Chemotherapy. 13(suppl B). 113–120. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luis Resel Breakdown of academic impact, for papers by Christian Wallner Breakdown of academic impact, for papers by Joanna K. Chon Breakdown of academic impact, for papers by Tomohiko Yanagida Breakdown of academic impact, for papers by Roberto L. Müller Breakdown of academic impact, for papers by Toshifumi Nakamura Breakdown of academic impact, for papers by N. Nakamura Breakdown of academic impact, for papers by Harry Nísen Breakdown of academic impact, for papers by Norman Heyden Breakdown of academic impact, for papers by Hsiang‐Ying Lee
Rankless by CCL
2026